marijuana stock news

Form 8-K for 22ND CENTURY GROUP, INC.

9-Jan-2015

Other Events, Financial Statements and Exhibits

Item 8.01. Other Events.On January 9, 2015, 22nd Century Group, Inc. (the “Company”) filed with the Securities and Exchange Commission a prospectus supplement dated January 9, 2015, to the prospectus dated June 5, 2014, filed as part of the Company’s effective registration statement on Form S-3 (SEC File No. 333-195386). The prospectus supplement relates to the offer and sale of up to 300,000 shares of the Company’s common stock covered by the registration statement.

Item 9.01. Financial Statements and Exhibits.(d) The following exhibits are being filed herewith:

Exhibit 5.1 Opinion of Foley & Lardner LLP
Exhibit 23.1 Consent of Foley & Lardner LLP (included in Exhibit 5.1)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

VPR Brands, LP (VPRB) Receives Favorable Decision from The US Patent Trial and Appeal Board (PTAB)

VPR Brands Receives Favorable Decision from The US Patent Trial and Appeal…

$MSRT Makes Top 10 in Extreme Tech Challenge

MassRoots Makes Top 10 in Extreme Tech Challenge, to Present on Stage…

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting

LONDON, April 12, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) “GW,”…

 Medical Marijuana, Inc. (MJNA) CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19

Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of…